Lymphoscintigraphy in Cutaneous Melanoma: An Updated Total Body Atlas of Sentinel Node Mapping

Published Online:

Lymphoscintigraphy has become part of the standard of care for patients with a new or recurrent diagnosis of melanoma, in helping determine the status of regional lymph nodes. Correct identification of sentinel lymph nodes enables the surgeon to further delineate the extent of malignancy by allowing sampling of the appropriate nodal group. Performing the lymphoscintigraphy prior to the planned operation allows limited surgery with less extensive postoperative morbidity. For this reason, a thorough knowledge of the lymph node drainage patterns from the different primary tumor locations, as well as of proper lymphoscintigraphic techniques and radiopharmaceuticals, constitutes an important armamentarium in the hands of surgeons, radiologists, and nuclear medicine physicians.

© RSNA, 2009


  • 1 American Cancer Society. Cancer facts and figures, 2008. Available at: Accessed August 2, 2008. Google Scholar
  • 2 National Cancer Institute. SEER stat fact sheet: melanoma of the skin. Available at: Accessed August 2, 2008. Google Scholar
  • 3 RiesLAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975–2005. Available at: Accessed August 2, 2008. Google Scholar
  • 4 BalchCM, Soong SJ, Gershenwald JE, et al. Prognostic factor analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol2001; 19: 3622–3634. Crossref, MedlineGoogle Scholar
  • 5 MortonDL, Thompson JF, Cochran AJ, et al. Sentinel node biopsy or nodal observation in melanoma. N Engl J Med2006; 355: 1307–1317. Crossref, MedlineGoogle Scholar
  • 6 MortonDL, Wen D, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg1992; 127: 392–399. Crossref, MedlineGoogle Scholar
  • 7 AlexJC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol1993; 2: 303–308. Crossref, MedlineGoogle Scholar
  • 8 CascinelliN, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol2000; 7: 469–474. Crossref, MedlineGoogle Scholar
  • 9 ReintgenD, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg1994; 220: 759–767. Crossref, MedlineGoogle Scholar
  • 10 ClaryBM, Brady MS, Lewis JJ, Coit DG. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg2001; 233: 250–258. Crossref, MedlineGoogle Scholar
  • 11 GershenwaldJE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or stage II melanoma. J Clin Oncol1998; 16: 2253–2260. Crossref, MedlineGoogle Scholar
  • 12 KarimRZ, Scolyer RA, Li W, et al. False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology. Ann Surg2008; 247: 1003–1010. Crossref, MedlineGoogle Scholar
  • 13 ThompsonJF, Scolyer RA. Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer. Pathology2004; 36: 496–504. Crossref, MedlineGoogle Scholar
  • 14 EverettM, Gutman H. Lymphatic drainage of calf melanoma skipping the superficial groin. Lymphat Res Biol2007; 5: 265–268. Crossref, MedlineGoogle Scholar
  • 15 UrenRF, Howman-Giles R, Thompson JF, et al. Lymphatic drainage to triangular intramuscular space lymph nodes in melanoma on the back. J Nucl Med1996; 37: 964–966. MedlineGoogle Scholar
  • 16 MoloneyDM, Overstall S, Allan R, Powell BW. An aberrant lymph node containing metastatic melanoma detected by sentinel node biopsy. Br J Plast Surg2001; 54: 638–640. Crossref, MedlineGoogle Scholar
  • 17 IntenzoCM, Kim SM, Patel JI, Lin HC, Kairys JC. Lymphoscintigraphy in cutaneous melanoma: a total body atlas of sentinel node mapping. RadioGraphics2002; 22: 491–502. LinkGoogle Scholar
  • 18 HungJC, Wiseman GA, Wahner HW, Mullan BP, Taggart TR, Dunn WL. Filtered Tc-99m sulfur colloid evaluated for lymphoscintigraphy. J Nucl Med1995; 36: 1895–1901. MedlineGoogle Scholar
  • 19 OsborneMP, Jeyasingh K, Jewkes RF, Burn I. The preoperative detection of internal mammary lymph node metastases in breast cancer. Br J Surg1979; 66: 813–818. Crossref, MedlineGoogle Scholar
  • 20 WilhelmAJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymph node detection: an overview. Eur J Nucl Med1999; 26(4 suppl): S36–S42. Crossref, MedlineGoogle Scholar
  • 21 GlassEC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med1998; 39: 1185–1190. MedlineGoogle Scholar
  • 22 UrenRF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med1993; 34: 1435–1440. MedlineGoogle Scholar
  • 23 EshimaD, Eshima LA, Gotti NM, et al. Tc-99m sulfur colloid for lymphoscintigraphy: effects of preparation parameters. J Nucl Med1996; 37: 1575–1578. MedlineGoogle Scholar
  • 24 GoldfarbLR, Alazraki NP, Eshima D, Eshima LA, Herda SC, Halkar RK. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid. Radiology1998; 208: 505–509. LinkGoogle Scholar
  • 25 BourgeoisP. Scintigraphic investigations of the lymphatic system: the influence of injected volume and quantity of labeled colloidal tracer. J Nucl Med2007; 48: 693–695. Crossref, MedlineGoogle Scholar
  • 26 ScarsbrookAF, Ganeshan A, Bradley KM. Pearls and pitfalls of radionuclide imaging of the lymphatic system. I. Sentinel node lymphoscintigraphy in malignant melanoma. Br J Radiol2007; 80: 132–139. Crossref, MedlineGoogle Scholar
  • 27 RettenbacherL, Koller J, Kässmann H, Holzmannhofer J, Rettenbacher T, Galvan G. Reproducibility of lymphoscintigraphy in cutaneous melanoma: can we accurately detect the sentinel lymph node by expanding the tracer injection distance from the tumor site? J Nucl Med2001; 42: 424–429. MedlineGoogle Scholar
  • 28 Martinez-EscribanoJA, Navarro JL, Pinero A, et al. Does injection distance of the radiocolloid modify lymphatic mapping in melanoma? Dermatol Surg2001; 27: 881–884. Crossref, MedlineGoogle Scholar
  • 29 BermanCG, Choi J, Hersh MR, Clark RA. Melanoma lymphoscintigraphy and lymphatic mapping. Semin Nucl Med2000; 30: 49–55. Crossref, MedlineGoogle Scholar
  • 30 MarianiG, Gipponi M, Moresco L, et al. Radio-guided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med2002; 43: 811–827. MedlineGoogle Scholar
  • 31 SzubaA, Shin W, Strauss W, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med2003; 44: 43–57. MedlineGoogle Scholar
  • 32 LynchPM, Delano FA, Schmid-Schonbein GW. The primary valves in the initial lymphatics during inflammation. Lymphat Res Biol2007; 5: 3–10. Crossref, MedlineGoogle Scholar
  • 33 MortonDL, Chan AD. Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? J Am Coll Surg1999; 189: 214–223. Crossref, MedlineGoogle Scholar

Article History

Published in print: July 2009